Rankings
▼
Calendar
ORKA Q2 2017 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ORKA
Oruka Therapeutics, Inc.
$1B
Q2 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$7,000
Operating Income
-$6M
Net Income
-$6M
EPS (Diluted)
$-127.91
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$17M
Total Liabilities
$3M
Stockholders' Equity
$15M
Cash & Equivalents
$9M
← FY 2017
All Quarters
Q3 2017 →
